of tumors in the laboratory
This proprietary technique provides a much more relevant model of a patient tumor that could be used for testing of drugs for personalized therapeutics or for the development of new drugs. We are validating this novel PDx approach firstly in Ovarian Cancer which complements the work being done to validate our AI-driven predictive models.
TumorGenesis PDx models will be offered in conjunction with current PDx animal model projects. Unlike current PDx animal models, the TumorGenesis tumor modeling approach is faster, less costly and more closely mimics the characteristics of the patient’s tumor.
We believe our novel TumorGenesis tumor modeling could provide pharmaceutical companies newfound ability for more effective and expeditious drug development and subsequently improve patient outcomes.